Historique
Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.52, n°4 - September-October 2020
Paru le :
01/10/2020
Année
2020
Page(s) :
289-382
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy. Luoma J.B., Chwyl C., Bathje G.J., Davis A.K., Lancelotta R., p. 289-299.
- The viability of microdosing psychedelics as a strategy to enhance cognition and well-being - An early review. Bornemann J., p. 300-308.
- Mystical experiences in retrospective reports of first times using a psychedelic in Finland. Kangaslampi S., Hausen A., Rauteenmaa T., p. 309-318.
- Can psychedelics alleviate symptoms of cluster headache and accompanying mental health problems? A case report involving Hawaiian baby woodrose. Johnson S., Black Q.C., p. 319-323.
- Increasing willingness to use synthetic drugs if offered among electronic dance music party attendees, 2017-2019. Palamar J.J., p. 324-333.
- Recent use of synthetic cannabinoids, synthetic opioids, and other psychoactive drug groups among high-risk drug users. Shapira B., Berkovitz R., Rosca P., Neumark Y., p. 334-343.
- Patterns of simultaneous polysubstance use among partygoers: Correlates and differences in adverse acute effects experienced. Fernandez-Calderon F., Vidal-Giné C., Rojas-Tejada A.J., Lozano-Rojas O.M., p. 344-356.
- Does self-change occur among severely dependent substance users? Chen G., Gueta K., Ronel N., p. 357-365.
- The influence of alexithymia on alcohol craving, health-related quality of life and gender in alcohol-dependent outpatients. Thorberg F.A., Hasking P., Huang Y.-L., Lyvers M., Young R.M., Connor J.P., et al., p. 366-376.
- Public health and medicine's need to respond to cannabis commercialization in the United States: A commentary. Bowling C.M., Hafez A.Y., Glantz S.A., p. 377-382.
- A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy. Luoma J.B., Chwyl C., Bathje G.J., Davis A.K., Lancelotta R., p. 289-299.
- The viability of microdosing psychedelics as a strategy to enhance cognition and well-being - An early review. Bornemann J., p. 300-308.
- Mystical experiences in retrospective reports of first times using a psychedelic in Finland. Kangaslampi S., Hausen A., Rauteenmaa T., p. 309-318.
- Can psychedelics alleviate symptoms of cluster headache and accompanying mental health problems? A case report involving Hawaiian baby woodrose. Johnson S., Black Q.C., p. 319-323.
- Increasing willingness to use synthetic drugs if offered among electronic dance music party attendees, 2017-2019. Palamar J.J., p. 324-333.
- Recent use of synthetic cannabinoids, synthetic opioids, and other psychoactive drug groups among high-risk drug users. Shapira B., Berkovitz R., Rosca P., Neumark Y., p. 334-343.
- Patterns of simultaneous polysubstance use among partygoers: Correlates and differences in adverse acute effects experienced. Fernandez-Calderon F., Vidal-Giné C., Rojas-Tejada A.J., Lozano-Rojas O.M., p. 344-356.
- Does self-change occur among severely dependent substance users? Chen G., Gueta K., Ronel N., p. 357-365.
- The influence of alexithymia on alcohol craving, health-related quality of life and gender in alcohol-dependent outpatients. Thorberg F.A., Hasking P., Huang Y.-L., Lyvers M., Young R.M., Connor J.P., et al., p. 366-376.
- Public health and medicine's need to respond to cannabis commercialization in the United States: A commentary. Bowling C.M., Hafez A.Y., Glantz S.A., p. 377-382.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
J. J. PALAMAR
|
2020
Dans Journal of Psychoactive Drugs (Vol.52, n°4, September-October 2020) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.52, n°4, September-October 2020) Article : Périodique
Intention and willingness to use drugs are proximal predictors of drug use; however, willingness to use requires more research to inform prevention efforts. This study examines willingness to use drugs among electronic dance music (EDM) party at[...]